secwatch.observer — SEC 8-K summary
======================================

Issuer:     QT IMAGING HOLDINGS, INC. (QTI)
CIK:        0001844505
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001844505-24-000044
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QT Imaging Q2 2024 revenue $1.7M, 51% gross margin; partners with OU cancer center
--------------------------------------------------------------------------------

- Revenue of $1.7M in Q2 2024, up from $1.4M in Q1 2024 and <$0.1M in Q2 2023.
- Gross margin of 51%, down from 56% QoQ due to weighted average cost variability.
- Shipped four Breast Acoustic CT scanners in Q2; three via strategic distributor; now five U.S. commercial sites.
- Signed U.S. exclusive distribution agreement and partnership with University of Oklahoma/OU Health Stephenson Cancer Center for AI/ML development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844505/000184450524000044/0001844505-24-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844505/000184450524000044/qti-20240808.htm
  HTML page:      https://secwatch.observer/filing/0001844505-24-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer